Lucozade, Ribena sale
British pharmaceuticals company GlaxoSmithKline is to sell brands Lucozade and Ribena, which could fetch more than £1 billion ($1.48 billion).
British pharmaceuticals company GlaxoSmithKline is to sell brands Lucozade and Ribena, which could fetch more than £1 billion ($1.48 billion).
Share this article and show your support
Call 1300 880 160
Start a chat
Schedule a call
